It's transformative, so no.
Legally, using the tests to help create the reimplementation is fine.
However, it seems possible you can't redistribute the same tests under the MIT license. So the reimplementation MIT distribution could need to be source code only, not source code plus tests. Or, the tests can be distributed in parallel but still under LGPL, not MIT. It doesn't really matter since compiled software won't be including the tests anyways.
> It's transformative, so no.
I'm not following your logic there, and I don't see any mention of "transformative" in the license. Can you explain what you mean?
loading story #47316356